1999
DOI: 10.1016/s0024-3205(99)00331-8
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced accumulation of pericardial fluid adenosine and inosine in patients with coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 26 publications
0
13
0
Order By: Relevance
“…Hypoxanthine is further metabolized to xanthine and urate by xanthine dehydrogenase or xanthine oxidase and it can be converted to inosine [27]. It has been considered that xanthine oxidase generated excess oxygen-free radicals, then caused ischemia injury in the pathway [28][29][30], and the enhanced release of inosine in plasma was a marker of ischemic myocardium [31]. Moreover, superoxide reacts at diffusion limited rates with other free radicals, particularly with NO to form the potent oxidant peroxynitrite, which has been shown to activate metalloproteinases and degrade troponin I, contributing to depressed myocardial function [32][33][34].…”
Section: Cdt Protectionmentioning
confidence: 99%
“…Hypoxanthine is further metabolized to xanthine and urate by xanthine dehydrogenase or xanthine oxidase and it can be converted to inosine [27]. It has been considered that xanthine oxidase generated excess oxygen-free radicals, then caused ischemia injury in the pathway [28][29][30], and the enhanced release of inosine in plasma was a marker of ischemic myocardium [31]. Moreover, superoxide reacts at diffusion limited rates with other free radicals, particularly with NO to form the potent oxidant peroxynitrite, which has been shown to activate metalloproteinases and degrade troponin I, contributing to depressed myocardial function [32][33][34].…”
Section: Cdt Protectionmentioning
confidence: 99%
“…All samples were collected into syringes containing ice-cold stop solution prepared with 400 µmol\l dipyridamole and 100 µmol\l EHNA [erythro-4-(2-hydroxy-3-nonil)adenine hydrochloride] to prevent further degradation of the purine metabolites, since a high degree of degradation of adenosine is expected on the basis of earlier studies [4,6,15,16].…”
Section: Experimental Protocolmentioning
confidence: 99%
“…Human and experimental animal studies have demonstrated that the pericardial fluid (PF), which is present in the intrapericardial space, not only serves a mechanical function but also accumulates several endogenous regulatory agents of cardiac origin [1][2][3][4][5][6]. The purine metabolites, such as adenosine and its degradative products inosine and hypoxanthine, play an important cardioprotective role as a part of an endogenous metabolic coronary adaptative mechanism.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The pericardial levels of the potent vasoconstrictor ET-1 and the cardioprotective and vasodilator adenine nucleosides are also found to exceed their plasma concentrations and may be substantially elevated in different cardiovascular diseases, such as ischemic heart disease [15,16].…”
Section: Introductionmentioning
confidence: 99%